Advanced Chemorefractory Colorectal Adenocarcinoma
1 clinical trials · Condition
◉ Watch Advanced Chemorefractory Colorectal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C) (NCT01929616) | Jules Bordet Institute | 2013-08-01 |
Track Advanced Chemorefractory Colorectal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.